Vyant Bio Balance Sheet Health
Financial Health criteria checks 3/6
Vyant Bio has a total shareholder equity of $4.5M and total debt of $57.0K, which brings its debt-to-equity ratio to 1.3%. Its total assets and total liabilities are $6.2M and $1.7M respectively.
Key information
1.3%
Debt to equity ratio
US$57.00k
Debt
| Interest coverage ratio | n/a |
| Cash | US$2.80m |
| Equity | US$4.50m |
| Total liabilities | US$1.73m |
| Total assets | US$6.23m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1C80's short term assets ($3.4M) exceed its short term liabilities ($1.2M).
Long Term Liabilities: 1C80's short term assets ($3.4M) exceed its long term liabilities ($526.0K).
Debt to Equity History and Analysis
Debt Level: 1C80 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 1C80's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1C80 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 1C80 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 21.4% each year